Avelumab: A Review in Metastatic Merkel Cell Carcinoma
In conclusion, currently available data suggest that avelumab present s a clinically beneficial new treatment option for metastatic MCC, a rare but aggressive cancer associated with a poor prognosis.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Japan Health | Merkel Cell Carcinoma | Study